Vimpat and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Vimpat (lacosamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ramipril, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Vimpat. It is created by eHealthMe based on reports of 20,279 people who have side effects when taking Vimpat from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,079 drugs and 1,420 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Apr, 27, 2026

20,279 people reported to have side effects when taking Vimpat.
Among them, 12 people (0.06%) have Hyperthyroid.

Among these 12 people:

How long have people been on Vimpat when they have Hyperthyroid? *

What is the gender of people who have Hyperthyroid when taking Vimpat? *

female: 50 %
male: 50 %

What is the age of people who have Hyperthyroid when taking Vimpat? *

What are other drugs people take besides Vimpat? *

What are other side effects people have besides Hyperthyroid? *

Fatigue (feeling of tiredness): 4 people, 33.33%
Thyroiditis (inflammation of thyroid gland): 4 people, 33.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 33.33%
Peripheral Nerve Paresis: 3 people, 25.00%
Muscle Aches (muscle pain): 3 people, 25.00%
Muscle Spasms (muscle contraction): 3 people, 25.00%
Myositis (inflammation of the muscles): 3 people, 25.00%
Myopathy (a muscular disease in which the muscle fibres do not function): 3 people, 25.00%
Rashes (redness): 3 people, 25.00%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 16.67%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 4 people, 33.33%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 16.67%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vimpat:

Vimpat (20,831 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,832 reports)

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,079 drugs)

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,420 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.